Published in Diabetes Care on November 01, 2003
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ (2007) 3.95
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J (2010) 2.68
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2013) 2.15
Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest (2006) 1.55
Pioglitazone initiation and subsequent hospitalization for congestive heart failure. Diabet Med (2005) 1.38
Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol (2010) 1.36
The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies. BMC Cardiovasc Disord (2014) 1.08
Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am (2012) 1.04
The phospholipase A(2) inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice. Br J Pharmacol (2009) 1.03
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study: response to Delea et al. Diabetes Care (2004) 0.93
Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation. Am J Transplant (2012) 0.93
Management of hyperglycemia in hospitalized patients. Ann N Y Acad Sci (2010) 0.92
Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.86
Heart failure in the diabetic population - pathophysiology, diagnosis and management. Arch Med Sci (2014) 0.86
Molecular determinants of the cardiometabolic phenotype. Endocr Metab Immune Disord Drug Targets (2010) 0.84
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes. Vasc Health Risk Manag (2010) 0.83
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients. Health Qual Life Outcomes (2011) 0.80
Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of thiazolidinediones for diabetes. BMC Health Serv Res (2011) 0.78
PPARs: Protectors or Opponents of Myocardial Function? PPAR Res (2015) 0.77
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database. BMC Clin Pharmacol (2011) 0.77
The possible role of peroxisome proliferator-activated receptor gamma in heart failure. Exp Clin Cardiol (2004) 0.75
The effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort study. Ther Clin Risk Manag (2016) 0.75
Does pioglitazone prevent macrovascular events in patients with type 2 diabetes? CMAJ (2006) 0.75
[Diabetes and heart failure]. Herz (2010) 0.75
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 5.86
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
It's time to overcome clinical inertia. Ann Intern Med (2008) 3.85
Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry (2003) 3.48
Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol (2012) 3.47
Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials (2008) 3.24
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care (2010) 3.12
Patient adherence improves glycemic control. Diabetes Educ (2005) 2.69
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis (2009) 2.41
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med (2006) 2.37
Therapy switching in patients receiving long-acting opioids. Ann Pharmacother (2004) 2.14
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. Value Health (2004) 2.05
Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain (2004) 1.92
Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care (2003) 1.91
Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ (2005) 1.89
Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst (2013) 1.80
Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer (2006) 1.61
Is sepsis accurately coded on hospital bills? Value Health (2002) 1.60
Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother (2011) 1.58
Validity of the primary care diagnosis of diabetes in veterans in the southeastern United States. Diabetes Res Clin Pract (2010) 1.57
Little time for diabetes management in the primary care setting. Diabetes Educ (2004) 1.53
Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care (2009) 1.52
Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause (2014) 1.50
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Invest (2002) 1.49
The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology (2004) 1.47
Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care (2010) 1.44
Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care (2009) 1.43
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol (2008) 1.41
Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Vaccine (2009) 1.40
Opioid use and health care charges at the end of life in patients with metastatic cancer. Manag Care Interface (2004) 1.38
Limited health care access impairs glycemic control in low income urban African Americans with type 2 diabetes. J Health Care Poor Underserved (2005) 1.33
Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. Am J Clin Nutr (2011) 1.31
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality. BMC Cancer (2011) 1.30
Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med (2008) 1.28
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol (2006) 1.28
Economic costs of nonmedical use of prescription opioids. Clin J Pain (2011) 1.22
Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr (2011) 1.22
A simple meal plan emphasizing healthy food choices is as effective as an exchange-based meal plan for urban African Americans with type 2 diabetes. Diabetes Care (2003) 1.20
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control (2012) 1.17
Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2008) 1.15
Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? Ann Pharmacother (2006) 1.15
Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health Syst Pharm (2006) 1.12
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Clin Ther (2009) 1.10
Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens (2007) 1.10
Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect (Larchmt) (2008) 1.09
Association of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes. Arch Intern Med (2003) 1.08
The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2010) 1.08
Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res (2012) 1.06
The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer. Value Health (2002) 1.04
Determinants of racial/ethnic disparities in incidence of diabetes in postmenopausal women in the U.S.: The Women's Health Initiative 1993-2009. Diabetes Care (2012) 1.04
Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes (2007) 1.03
Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.03
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02
Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol (2010) 1.02
Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes. J Proteome Res (2008) 1.01
Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res (2006) 1.01
Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease. Arch Intern Med (2002) 1.01
Effectiveness of bisphosphonate therapy in a community setting. Bone (2008) 1.01
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. J Rheumatol (2011) 1.00
Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Clin Ther (2008) 1.00
Dose intensification with infliximab in patients with rheumatoid arthritis. Ann Pharmacother (2005) 1.00
Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab (2010) 1.00
Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. Am J Clin Oncol (2012) 0.99
A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women. Diabetes (2012) 0.98
Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative. Circulation (2004) 0.98
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res (2011) 0.98
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care (2005) 0.97
Evidence of reduced β-cell function in Asian Indians with mild dysglycemia. Diabetes Care (2013) 0.96
Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol (2007) 0.96
Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. Curr Med Res Opin (2009) 0.96
Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol (2009) 0.96
A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women. J Nutr (2011) 0.96
Adherence with migraine prophylaxis in clinical practice. Pain Pract (2012) 0.95
Insulin-response element-binding protein 1: a novel Akt substrate involved in transcriptional action of insulin. J Biol Chem (2004) 0.94
Screening for diabetes and prediabetes should be cost-saving in patients at high risk. Diabetes Care (2013) 0.93
Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*. Curr Med Res Opin (2008) 0.92
Weight change and cognitive function: findings from the Women's Health Initiative Study of Cognitive Aging. Obesity (Silver Spring) (2011) 0.92
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care (2010) 0.92
Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders. Curr Med Res Opin (2009) 0.92
Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5). Diabetes Care (2008) 0.92
Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum (2011) 0.91
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists. J Rheumatol (2008) 0.90
Use of a uniform treatment algorithm abolishes racial disparities in glycemic control. Diabetes Educ (2008) 0.90
Effects of a low-fat dietary intervention on glucose, insulin, and insulin resistance in the Women's Health Initiative (WHI) Dietary Modification trial. Am J Clin Nutr (2011) 0.90
Blood pressure control in patients initiating antihypertensive therapy. Ann Pharmacother (2008) 0.89
Diabetes care in black and white veterans in the southeastern U.S. Diabetes Care (2010) 0.89
Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. J Thorac Oncol (2006) 0.88
Serum 25-hydroxyvitamin D and physical performance in postmenopausal women. J Womens Health (Larchmt) (2011) 0.88
Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin (2008) 0.88
Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia. J Psychiatr Res (2008) 0.88
Utility of casual postprandial glucose levels in type 2 diabetes management. Diabetes Care (2004) 0.88
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States. Am J Hematol (2008) 0.87